(Q39473320)

English

Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection

scientific article published on 19 August 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection (English)

1 reference

Europe PubMed Central

12 September 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yi-Hsiang Huang

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

10

object named as

Tzeng-Ji Chen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Pei-Chang Lee

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chiu-Mei Yeh

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chun-Chia Chen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chia-Jen Liu

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chien-Wei Su

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Teh-Ia Huo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yee Chao

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Han-Chieh Lin

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jaw-Ching Wu

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

19 August 2016

1 reference

Europe PubMed Central

12 September 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Suppl 5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

874-883

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27541812%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

https://scigraph.springernature.com/pub.10.1245/s10434-016-5520-9

0 references

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Management of HCC

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

The global epidemiology of hepatocellular carcinoma: present and future

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Chemopreventive strategies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Resection of hepatocellular cancer ≤2 cm: results from two Western centers.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Inhibition of hepatitis B virus-associated liver cancer by antiplatelet therapy: a revolution in hepatocellular carcinoma prevention?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Immunobiology and pathogenesis of viral hepatitis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Platelets and the immune continuum

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Platelets harness the immune response to drive liver cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Reducing the risks of gastrointestinal bleeding with antiplatelet therapies

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-016-5520-9

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39473320&oldid=1829826328"